After The Stock Fell -6.12% Over The Week, Is Cytek BioSciences Inc (NASDAQ: CTKB) Still A Buy?
Cytek BioSciences Inc (NASDAQ:CTKB)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 1.31. At the close of